首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >ADVERSE DRUG REACTIONS TO CANCER CHEMOTHERAPY IN A REGIONAL CANCER CENTER IN NORTHEAST INDIA
【24h】

ADVERSE DRUG REACTIONS TO CANCER CHEMOTHERAPY IN A REGIONAL CANCER CENTER IN NORTHEAST INDIA

机译:印度东北地区癌症中心的药物化疗不良反应

获取原文
获取外文期刊封面目录资料

摘要

Background: With the dramatic advances in the medical science, treatment of many cancers is not just palliative, but rather curative in today’s world. The dosage regimen and the method of administration can greatly affect their efficacy and toxicity. Aims and Objects: To study the patterns of adverse drug reaction to cancer chemotherapy and to assess the causality, severity and predictability of those adverse reactions. Materials and Methods: The study was conducted in the department of Radiotherapy for a period of 6 months. It is a prospective study and included all in-patients & outpatients with adverse effects during the study period. The data was collected using ADR (adverse drug reaction) form designed by CDSCO (Centre for Drug Standard Control Organization) and statistical analysis was done using SPSS 20. Results: A total of 224 adverse reactions were noted in 178 patients with M:F ratio of 1:1.5. 54.5 % of the reactions were observed in age group of 40-60 years. The most common single drug causing reaction is cisplatin and regimen is CHOP regimen. Anemia is the most commonly seen side effect. Most of the reactions were probable in causality, moderate in severity and unpredictable in nature. Conclusion: Chemotherapeutic drugs have a narrow therapeutic index and the dosage needed to achieve a therapeutic response usually proves toxic to the body’s rapidly proliferating cells. Hence by early detection of the reaction and by prophylactic management, treatment can be made effective.
机译:背景:随着医学科学的飞速发展,当今世界,许多癌症的治疗不仅是姑息疗法,而且是治愈方法。剂量方案和给药方法可极大地影响其功效和毒性。目的和目的:研究药物对癌症化学疗法的不良反应模式,并评估这些不良反应的因果关系,严重性和可预测性。材料和方法:该研究在放疗科进行了6个月。这是一项前瞻性研究,涵盖了研究期间所有不良反应的住院和门诊患者。使用CDSCO(药物标准控制组织中心)设计的ADR(药物不良反应)表格收集数据,并使用SPSS 20进行统计分析。结果:在178例M:F比率的患者中共发现224种不良反应1:1.5。在40-60岁年龄组中观察到54.5%的反应。引起反应的最常见的单一药物是顺铂,方案是CHOP方案。贫血是最常见的副作用。大多数反应很可能是因果关系,严重程度中等,本质上是不可预测的。结论:化学治疗药物的治疗指数很窄,达到治疗反应所需的剂量通常证明对人体迅速增殖的细胞有毒。因此,通过早期检测反应并通过预防性处理,可以使治疗有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号